Hinge Health, Inc. — Cyborg Score 7/10

Strong
Digital Health / Musculoskeletal Care Automation

Strategic Profile

As a high-growth healthcare automation company, Hinge Health targets cost-conscious self-insured employers seeking to reduce expensive orthopedic surgeries and employee downtime. The company demonstrates strong commercial momentum with 51% revenue growth in 2025, expanding margins, and positive free cash flow, positioning itself as the leading platform in digital MSK care with significant expansion potential into adjacent healthcare markets.

Cyborg Score Rationale

Hinge Health shows exceptional top-line growth (51% YoY), record client expansion (25% increase in corporate customers to 2,830), and recent profitability inflection in Q4 2025. However, the company faced a significant GAAP net loss in 2025 overall, though this is gradually improving. Strong analyst support and impressive engagement metrics (47% YoY growth in platform users) support solid fundamentals.

Top Insights

  • Company achieved full-year revenue of $587.9M (51% growth) and Q4 profitability of $32M despite full-year GAAP losses, signaling margin expansion and path to sustained profitability
  • Corporate customer base grew 25% YoY to 2,830 clients serving 25M eligible lives, with platform engagement jumping 47% to 782,890 active users
  • Launched 'Robin' AI care assistant in November 2025 to help automate patient monitoring and reduce clinician burden while maintaining service quality
  • 2026 guidance of $732-742M revenue (+25% growth midpoint) reflects strong commercial momentum and management confidence in market penetration strategy

Named Competitors

  • Sword Health — AI-powered physical therapy and musculoskeletal pain management platform
  • Teladoc Health — Telehealth and virtual care platform with orthopedic services
  • Physical Therapy Services — Traditional in-person and emerging digital PT providers expanding automation capabilities

Recent Developments

  • (February 2026) Posted record Q4 2025 results with $170.7M revenue beat and $32M net income; 2026 guidance exceeded Street estimates
  • (February 2026) Multiple analyst price target reductions but maintained Buy/Overweight ratings from Stifel Nicolaus, KeyBanc, Canaccord, and Evercore ISI
  • (November 2025) Launched Robin AI care assistant and movement analysis features to enhance automation and reduce care team costs
  • (May 2025) Company IPO on NYSE under ticker HNGE

Open the full interactive Hinge Health, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →